About Beclin-2
Beclin-2 (BECN2) is a protein
from Homo sapiens identified by UniProt accession
A8MW95, 431 residues long.
MolForge cross-references it against 0 known binders and
46 disease associations.
Target properties
| Protein name | Beclin-2 |
| UniProt accession | A8MW95 |
| Gene | BECN2 |
| Organism | Homo sapiens |
| Length | 431 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (46)
Diseases linked to this target (Open Targets).
- MODY · score 0.07
- obesity due to melanocortin 4 receptor deficiency · score 0.06
- type 2 diabetes mellitus · score 0.05
- hypoinsulinemic hypoglycemia and body hemihypertrophy · score 0.05
- transient neonatal diabetes mellitus · score 0.05
- severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency · score 0.04
- metabolite measurement · score 0.04
- short stature due to primary acid-labile subunit deficiency · score 0.04
- diabetes mellitus, permanent neonatal 4 · score 0.04
- diabetes mellitus, transient neonatal, 2 · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-A8MW95-F1 | alphafold | PREDICTED | 75.92 | — |
Amino-acid sequence (431 residues)
MSSIRFLCQR CHQALKLSGS SESRSLPAAP APTSGQAEPG DTREPGVTTR EVTDAEEQQD GASSRSPPGD GSVSKGHANI FTLLGELGAM HMLSSIQKAA GDIFDIVSGQ AVVDHPLCEE CTDSLLEQLD IQLALTEADS QNYQRCLETG ELATSEDEAA ALRAELRDLE LEEARLVQEL EDVDRNNARA AADLQAAQAE AAELDQQERQ HYRDYSALKR QQLELLDQLG NVENQLQYAR VQRDRLKEIN CFTATFEIWV EGPLGVINNF RLGRLPTVRV GWNEINTAWG QAALLLLTLA NTIGLQFQRY RLIPCGNHSY LKSLTDDRTE LPLFCYGGQD VFLNNKYDRA MVAFLDCMQQ FKEEAEKGEL GLSLPYGIQV ETGLMEDVGG RGECYSIRTH LNTQELWTKA LKFMLINFKW SLIWVASRYQ K
Explore Beclin-2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets